Nikita Pozdeyev
Concepts (326)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroid Neoplasms | 13 | 2024 | 312 | 2.860 |
Why?
| Thyroid Nodule | 2 | 2025 | 56 | 1.720 |
Why?
| Thyroid Carcinoma, Anaplastic | 4 | 2020 | 35 | 1.510 |
Why?
| Retina | 13 | 2012 | 279 | 1.160 |
Why?
| Adrenal Cortex Neoplasms | 2 | 2021 | 60 | 0.830 |
Why?
| Adrenocortical Carcinoma | 2 | 2021 | 63 | 0.820 |
Why?
| Melatonin | 9 | 2009 | 125 | 0.820 |
Why?
| Carcinoma | 1 | 2025 | 214 | 0.820 |
Why?
| Circadian Rhythm | 10 | 2011 | 413 | 0.810 |
Why?
| Thyroxine | 1 | 2023 | 62 | 0.810 |
Why?
| Adenoma | 1 | 2025 | 214 | 0.810 |
Why?
| Hypothyroidism | 1 | 2023 | 70 | 0.800 |
Why?
| Dopamine | 11 | 2018 | 285 | 0.770 |
Why?
| Proto-Oncogene Proteins B-raf | 6 | 2023 | 210 | 0.740 |
Why?
| Carcinoma, Neuroendocrine | 1 | 2020 | 32 | 0.660 |
Why?
| Splenectomy | 1 | 2020 | 58 | 0.650 |
Why?
| Bacterial Vaccines | 1 | 2020 | 63 | 0.640 |
Why?
| Biomarkers, Tumor | 5 | 2024 | 1164 | 0.640 |
Why?
| Antigens, Neoplasm | 1 | 2020 | 308 | 0.560 |
Why?
| Drug Resistance, Neoplasm | 3 | 2021 | 752 | 0.510 |
Why?
| Pharmacogenomic Testing | 1 | 2016 | 61 | 0.500 |
Why?
| Guideline Adherence | 1 | 2020 | 527 | 0.490 |
Why?
| Databases, Genetic | 1 | 2016 | 230 | 0.470 |
Why?
| Antineoplastic Agents | 2 | 2016 | 2046 | 0.460 |
Why?
| NF-kappa B | 2 | 2015 | 665 | 0.450 |
Why?
| Neoplasm Recurrence, Local | 3 | 2024 | 958 | 0.440 |
Why?
| Sepsis | 1 | 2020 | 575 | 0.430 |
Why?
| Photoreceptor Cells, Vertebrate | 3 | 2012 | 26 | 0.420 |
Why?
| Mutation | 9 | 2021 | 3717 | 0.420 |
Why?
| Data Collection | 1 | 2016 | 650 | 0.420 |
Why?
| Genetic Variation | 1 | 2018 | 939 | 0.400 |
Why?
| Thyroidectomy | 3 | 2024 | 89 | 0.390 |
Why?
| Photoreceptor Cells | 3 | 2008 | 17 | 0.380 |
Why?
| Practice Guidelines as Topic | 1 | 2020 | 1501 | 0.380 |
Why?
| Genomics | 4 | 2024 | 718 | 0.370 |
Why?
| Ultrasonography | 2 | 2025 | 712 | 0.350 |
Why?
| Eye Proteins | 3 | 2008 | 89 | 0.320 |
Why?
| Signal Transduction | 4 | 2018 | 4931 | 0.320 |
Why?
| Adenocarcinoma, Follicular | 2 | 2019 | 34 | 0.310 |
Why?
| GTP-Binding Protein Regulators | 1 | 2008 | 2 | 0.300 |
Why?
| Oncogene Proteins, Fusion | 2 | 2021 | 201 | 0.290 |
Why?
| Cell Line, Tumor | 8 | 2021 | 3186 | 0.280 |
Why?
| Arylalkylamine N-Acetyltransferase | 2 | 2006 | 2 | 0.280 |
Why?
| 14-3-3 Proteins | 1 | 2006 | 18 | 0.260 |
Why?
| Humans | 28 | 2025 | 129627 | 0.260 |
Why?
| Phosphoproteins | 1 | 2008 | 335 | 0.250 |
Why?
| 3,4-Dihydroxyphenylacetic Acid | 7 | 2011 | 19 | 0.240 |
Why?
| Thyroglobulin | 1 | 2024 | 27 | 0.230 |
Why?
| MAP Kinase Signaling System | 2 | 2023 | 313 | 0.220 |
Why?
| Kynuramine | 1 | 2003 | 1 | 0.220 |
Why?
| Biological Clocks | 4 | 2008 | 40 | 0.210 |
Why?
| Lighting | 2 | 2000 | 24 | 0.210 |
Why?
| Computers | 1 | 2023 | 65 | 0.210 |
Why?
| Neoplasm Staging | 2 | 2018 | 1282 | 0.200 |
Why?
| Dopamine Agents | 2 | 2018 | 16 | 0.200 |
Why?
| Levodopa | 2 | 2018 | 30 | 0.200 |
Why?
| Thyrotropin | 1 | 2023 | 109 | 0.200 |
Why?
| Data Warehousing | 1 | 2022 | 5 | 0.190 |
Why?
| Cloud Computing | 1 | 2022 | 7 | 0.190 |
Why?
| Reoperation | 1 | 2024 | 541 | 0.190 |
Why?
| Models, Genetic | 1 | 2025 | 593 | 0.190 |
Why?
| Light | 4 | 2009 | 359 | 0.190 |
Why?
| Neoplasms | 1 | 2016 | 2455 | 0.190 |
Why?
| Retinal Rod Photoreceptor Cells | 3 | 2018 | 14 | 0.190 |
Why?
| Gene Frequency | 2 | 2025 | 502 | 0.190 |
Why?
| Immunohistochemistry | 5 | 2020 | 1685 | 0.180 |
Why?
| Receptor, Melatonin, MT1 | 2 | 2011 | 6 | 0.180 |
Why?
| Diagnosis, Differential | 1 | 2025 | 1432 | 0.170 |
Why?
| MutS Homolog 2 Protein | 1 | 2020 | 14 | 0.170 |
Why?
| Pheochromocytoma | 1 | 2021 | 57 | 0.170 |
Why?
| Thyroiditis, Autoimmune | 1 | 2020 | 15 | 0.170 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 151 | 0.170 |
Why?
| Night Blindness | 2 | 2012 | 6 | 0.170 |
Why?
| Paraganglioma | 1 | 2021 | 49 | 0.170 |
Why?
| Calcitonin | 1 | 2020 | 27 | 0.170 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 184 | 0.170 |
Why?
| Haemophilus influenzae type b | 1 | 2020 | 10 | 0.170 |
Why?
| Software | 1 | 2025 | 608 | 0.170 |
Why?
| Neisseria meningitidis | 1 | 2020 | 23 | 0.170 |
Why?
| Precision Medicine | 1 | 2024 | 387 | 0.170 |
Why?
| Trans-Activators | 2 | 2021 | 393 | 0.170 |
Why?
| Receptors, Virus | 1 | 2020 | 83 | 0.160 |
Why?
| Retrospective Studies | 4 | 2025 | 14522 | 0.160 |
Why?
| Neuroendocrine Tumors | 1 | 2021 | 99 | 0.160 |
Why?
| Organizational Case Studies | 1 | 2020 | 74 | 0.160 |
Why?
| Animals | 25 | 2021 | 35391 | 0.160 |
Why?
| Myopia | 2 | 2012 | 47 | 0.160 |
Why?
| Tyrosine | 1 | 2000 | 223 | 0.160 |
Why?
| Gene Expression Regulation, Neoplastic | 3 | 2021 | 1336 | 0.160 |
Why?
| Disease Susceptibility | 2 | 2020 | 334 | 0.160 |
Why?
| Sensitivity and Specificity | 1 | 2024 | 1843 | 0.160 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 169 | 0.160 |
Why?
| DNA Mutational Analysis | 1 | 2020 | 382 | 0.160 |
Why?
| Crk-Associated Substrate Protein | 1 | 2018 | 5 | 0.160 |
Why?
| Focal Adhesion Kinase 1 | 1 | 2018 | 32 | 0.150 |
Why?
| Immune System | 1 | 2020 | 175 | 0.150 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2018 | 53 | 0.150 |
Why?
| Leukocytes | 1 | 2020 | 306 | 0.150 |
Why?
| Postoperative Complications | 2 | 2023 | 2477 | 0.150 |
Why?
| src-Family Kinases | 1 | 2018 | 95 | 0.150 |
Why?
| Streptococcus pneumoniae | 1 | 2020 | 161 | 0.150 |
Why?
| Pharmacogenomic Variants | 1 | 2018 | 35 | 0.140 |
Why?
| Adrenal Cortex | 1 | 2018 | 27 | 0.140 |
Why?
| DNA Mismatch Repair | 1 | 2018 | 47 | 0.140 |
Why?
| Rod Opsins | 2 | 2009 | 7 | 0.140 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 259 | 0.140 |
Why?
| Oncogenes | 1 | 2018 | 110 | 0.140 |
Why?
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 33 | 0.140 |
Why?
| Neoplasm Grading | 1 | 2018 | 282 | 0.140 |
Why?
| Dark Adaptation | 3 | 2018 | 14 | 0.140 |
Why?
| Telomerase | 1 | 2019 | 234 | 0.130 |
Why?
| Amino Acids | 1 | 2000 | 487 | 0.130 |
Why?
| Photic Stimulation | 2 | 2008 | 241 | 0.130 |
Why?
| Diabetes Mellitus, Experimental | 1 | 2018 | 183 | 0.130 |
Why?
| Electroretinography | 5 | 2018 | 45 | 0.130 |
Why?
| Combined Modality Therapy | 2 | 2018 | 1203 | 0.130 |
Why?
| Gene Expression Profiling | 2 | 2020 | 1687 | 0.130 |
Why?
| Disease Management | 1 | 2020 | 588 | 0.120 |
Why?
| Diabetic Retinopathy | 1 | 2018 | 178 | 0.120 |
Why?
| Caspase 7 | 1 | 2015 | 22 | 0.120 |
Why?
| Tyrosine 3-Monooxygenase | 3 | 2018 | 71 | 0.120 |
Why?
| Tumor Suppressor Proteins | 1 | 2018 | 314 | 0.120 |
Why?
| Mice | 13 | 2021 | 16961 | 0.120 |
Why?
| Information Storage and Retrieval | 1 | 2016 | 108 | 0.120 |
Why?
| Bortezomib | 1 | 2015 | 45 | 0.120 |
Why?
| Hypocalcemia | 1 | 2015 | 28 | 0.120 |
Why?
| Inhibitory Concentration 50 | 1 | 2015 | 86 | 0.120 |
Why?
| User-Computer Interface | 1 | 2016 | 147 | 0.120 |
Why?
| Protein-Tyrosine Kinases | 1 | 2019 | 431 | 0.120 |
Why?
| Cell Proliferation | 3 | 2021 | 2373 | 0.120 |
Why?
| Disease Progression | 2 | 2020 | 2627 | 0.120 |
Why?
| Clinical Trials as Topic | 1 | 2020 | 1005 | 0.120 |
Why?
| Radiation, Ionizing | 1 | 2015 | 76 | 0.120 |
Why?
| Taxoids | 1 | 2015 | 98 | 0.120 |
Why?
| Genetic Testing | 1 | 2018 | 430 | 0.120 |
Why?
| Pharmacogenetics | 1 | 2016 | 172 | 0.120 |
Why?
| Mice, Knockout | 6 | 2018 | 2881 | 0.120 |
Why?
| Tumor Suppressor Protein p53 | 1 | 2019 | 507 | 0.120 |
Why?
| Caspase 3 | 1 | 2015 | 245 | 0.110 |
Why?
| Prognosis | 2 | 2024 | 3774 | 0.110 |
Why?
| Cell Death | 1 | 2015 | 354 | 0.110 |
Why?
| Computational Biology | 1 | 2018 | 596 | 0.110 |
Why?
| Promoter Regions, Genetic | 1 | 2018 | 1207 | 0.110 |
Why?
| Interleukin-8 | 1 | 2014 | 264 | 0.100 |
Why?
| Rats | 6 | 2010 | 5483 | 0.100 |
Why?
| Phosphorylation | 2 | 2008 | 1713 | 0.100 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2012 | 235 | 0.100 |
Why?
| Neoplasm Transplantation | 3 | 2019 | 256 | 0.100 |
Why?
| Models, Biological | 1 | 2020 | 1724 | 0.100 |
Why?
| Macrophages | 1 | 2020 | 1488 | 0.100 |
Why?
| Molecular Targeted Therapy | 1 | 2015 | 391 | 0.100 |
Why?
| Neovascularization, Pathologic | 1 | 2014 | 296 | 0.100 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2021 | 1560 | 0.100 |
Why?
| Retinal Bipolar Cells | 1 | 2012 | 7 | 0.100 |
Why?
| Female | 10 | 2024 | 68735 | 0.100 |
Why?
| Mice, Nude | 3 | 2021 | 682 | 0.100 |
Why?
| Male | 13 | 2024 | 63671 | 0.090 |
Why?
| Gene Expression Regulation | 3 | 2012 | 2542 | 0.090 |
Why?
| Calcium | 2 | 2015 | 1212 | 0.090 |
Why?
| Protein Kinase Inhibitors | 3 | 2023 | 887 | 0.090 |
Why?
| Dopamine Agonists | 2 | 2008 | 39 | 0.090 |
Why?
| Dopamine beta-Hydroxylase | 1 | 2010 | 13 | 0.090 |
Why?
| Rats, Wistar | 3 | 2001 | 442 | 0.090 |
Why?
| Disulfiram | 1 | 2010 | 14 | 0.090 |
Why?
| Homovanillic Acid | 2 | 2000 | 10 | 0.090 |
Why?
| Alcohol Deterrents | 1 | 2010 | 17 | 0.090 |
Why?
| Algorithms | 1 | 2018 | 1616 | 0.090 |
Why?
| Mice, Inbred C57BL | 5 | 2018 | 5455 | 0.080 |
Why?
| Middle Aged | 5 | 2024 | 31136 | 0.080 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2012 | 207 | 0.080 |
Why?
| Conditioning, Operant | 1 | 2010 | 104 | 0.080 |
Why?
| Obesity | 1 | 2023 | 2882 | 0.080 |
Why?
| Vision, Ocular | 1 | 2009 | 35 | 0.080 |
Why?
| Extinction, Psychological | 1 | 2010 | 91 | 0.080 |
Why?
| Chickens | 2 | 2006 | 189 | 0.080 |
Why?
| Light Signal Transduction | 1 | 2009 | 5 | 0.080 |
Why?
| Amacrine Cells | 1 | 2009 | 13 | 0.080 |
Why?
| Cyclic AMP | 2 | 2006 | 238 | 0.080 |
Why?
| Cocaine | 1 | 2010 | 149 | 0.070 |
Why?
| Dopamine Antagonists | 1 | 2008 | 23 | 0.070 |
Why?
| Receptors, Dopamine D4 | 1 | 2008 | 26 | 0.070 |
Why?
| Cells, Cultured | 4 | 2014 | 4084 | 0.070 |
Why?
| Disease Models, Animal | 3 | 2019 | 4078 | 0.070 |
Why?
| Visual Pathways | 1 | 2008 | 50 | 0.070 |
Why?
| Chromatography, High Pressure Liquid | 3 | 2011 | 580 | 0.070 |
Why?
| Apoptosis | 3 | 2021 | 2492 | 0.070 |
Why?
| Retinal Diseases | 1 | 2008 | 87 | 0.070 |
Why?
| Nerve Growth Factors | 1 | 2007 | 73 | 0.070 |
Why?
| Treatment Outcome | 4 | 2024 | 10219 | 0.070 |
Why?
| Adenylyl Cyclases | 1 | 2006 | 83 | 0.060 |
Why?
| Mammals | 1 | 2008 | 275 | 0.060 |
Why?
| Calmodulin | 1 | 2006 | 76 | 0.060 |
Why?
| RNA, Messenger | 6 | 2012 | 2708 | 0.060 |
Why?
| Darkness | 2 | 2009 | 25 | 0.060 |
Why?
| United States | 2 | 2020 | 13871 | 0.060 |
Why?
| Arylamine N-Acetyltransferase | 1 | 2005 | 5 | 0.060 |
Why?
| Imidazoles | 2 | 2021 | 234 | 0.060 |
Why?
| Neck Dissection | 1 | 2024 | 16 | 0.060 |
Why?
| Retinal Ganglion Cells | 1 | 2005 | 101 | 0.060 |
Why?
| Recurrent Laryngeal Nerve Injuries | 1 | 2024 | 13 | 0.060 |
Why?
| Enzyme Activation | 1 | 2006 | 813 | 0.060 |
Why?
| Early Growth Response Protein 1 | 1 | 2023 | 28 | 0.050 |
Why?
| Genetics, Population | 1 | 2025 | 200 | 0.050 |
Why?
| Lymph Node Excision | 1 | 2024 | 164 | 0.050 |
Why?
| Biological Specimen Banks | 1 | 2024 | 97 | 0.050 |
Why?
| Fibronectins | 1 | 2023 | 123 | 0.050 |
Why?
| Phenotype | 2 | 2023 | 3075 | 0.050 |
Why?
| Preoperative Care | 1 | 2024 | 338 | 0.050 |
Why?
| 1,2-Dimethylhydrazine | 1 | 2001 | 1 | 0.050 |
Why?
| Median Eminence | 1 | 2001 | 5 | 0.050 |
Why?
| Preoptic Area | 1 | 2001 | 6 | 0.050 |
Why?
| Suprachiasmatic Nucleus | 1 | 2001 | 15 | 0.050 |
Why?
| Biogenic Monoamines | 1 | 2001 | 15 | 0.050 |
Why?
| Oximes | 1 | 2021 | 22 | 0.050 |
Why?
| Risk Assessment | 2 | 2024 | 3262 | 0.040 |
Why?
| Carcinogens | 1 | 2001 | 110 | 0.040 |
Why?
| Models, Statistical | 1 | 2025 | 625 | 0.040 |
Why?
| Retinal Degeneration | 2 | 2012 | 34 | 0.040 |
Why?
| Indazoles | 1 | 2021 | 66 | 0.040 |
Why?
| Computer Simulation | 1 | 2025 | 939 | 0.040 |
Why?
| Protein Binding | 1 | 2006 | 2124 | 0.040 |
Why?
| Adrenal Gland Neoplasms | 1 | 2021 | 83 | 0.040 |
Why?
| Drug Synergism | 1 | 2021 | 370 | 0.040 |
Why?
| Oxidation-Reduction | 1 | 2003 | 1028 | 0.040 |
Why?
| Aged | 3 | 2024 | 22061 | 0.040 |
Why?
| Wnt Signaling Pathway | 1 | 2021 | 170 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2021 | 943 | 0.040 |
Why?
| Validation Studies as Topic | 1 | 2019 | 21 | 0.040 |
Why?
| Dasatinib | 1 | 2018 | 54 | 0.040 |
Why?
| Piperazines | 1 | 2021 | 340 | 0.040 |
Why?
| Luminescence | 1 | 2018 | 36 | 0.040 |
Why?
| Neurons | 1 | 2007 | 1494 | 0.040 |
Why?
| Pineal Gland | 2 | 2012 | 16 | 0.040 |
Why?
| Genome-Wide Association Study | 1 | 2025 | 1326 | 0.040 |
Why?
| Xenograft Model Antitumor Assays | 1 | 2021 | 808 | 0.040 |
Why?
| Aldosterone | 1 | 2018 | 43 | 0.040 |
Why?
| Oscillometry | 1 | 2018 | 37 | 0.040 |
Why?
| Cell Survival | 2 | 2012 | 1076 | 0.040 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2025 | 2060 | 0.030 |
Why?
| Germ-Line Mutation | 1 | 2018 | 142 | 0.030 |
Why?
| Drug Interactions | 2 | 2010 | 395 | 0.030 |
Why?
| Chick Embryo | 2 | 2006 | 130 | 0.030 |
Why?
| Blotting, Western | 2 | 2011 | 1206 | 0.030 |
Why?
| In Situ Hybridization | 2 | 2007 | 297 | 0.030 |
Why?
| Norepinephrine | 2 | 2010 | 210 | 0.030 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 487 | 0.030 |
Why?
| Follow-Up Studies | 1 | 2024 | 4894 | 0.030 |
Why?
| Transcriptome | 1 | 2021 | 876 | 0.030 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2014 | 53 | 0.030 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 949 | 0.030 |
Why?
| Cell Line | 1 | 2019 | 2784 | 0.030 |
Why?
| I-kappa B Proteins | 1 | 2014 | 79 | 0.030 |
Why?
| Colorado | 1 | 2024 | 4404 | 0.030 |
Why?
| Body Weight | 1 | 2018 | 940 | 0.030 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 102 | 0.030 |
Why?
| Mucoproteins | 1 | 2012 | 10 | 0.020 |
Why?
| Opsins | 1 | 2012 | 11 | 0.020 |
Why?
| Bromodeoxyuridine | 1 | 2012 | 78 | 0.020 |
Why?
| Nerve Tissue Proteins | 2 | 2006 | 569 | 0.020 |
Why?
| Microarray Analysis | 1 | 2012 | 116 | 0.020 |
Why?
| Oncogene Proteins | 1 | 2012 | 55 | 0.020 |
Why?
| Microscopy, Electron, Transmission | 1 | 2012 | 146 | 0.020 |
Why?
| Eye Diseases, Hereditary | 1 | 2012 | 11 | 0.020 |
Why?
| Genetic Diseases, X-Linked | 1 | 2012 | 24 | 0.020 |
Why?
| Adult | 2 | 2024 | 35600 | 0.020 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2012 | 41 | 0.020 |
Why?
| Mice, Inbred C3H | 1 | 2012 | 272 | 0.020 |
Why?
| Neoplasm Metastasis | 1 | 2014 | 611 | 0.020 |
Why?
| Transcription Factors | 2 | 2012 | 1647 | 0.020 |
Why?
| Heterozygote | 1 | 2012 | 275 | 0.020 |
Why?
| Gene Knockdown Techniques | 1 | 2012 | 317 | 0.020 |
Why?
| Pedigree | 1 | 2012 | 487 | 0.020 |
Why?
| Chromosome Mapping | 1 | 2012 | 505 | 0.020 |
Why?
| Thiones | 1 | 2010 | 14 | 0.020 |
Why?
| Self Administration | 1 | 2010 | 120 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 399 | 0.020 |
Why?
| Analysis of Variance | 1 | 2012 | 1293 | 0.020 |
Why?
| Adaptation, Biological | 1 | 2009 | 55 | 0.020 |
Why?
| Food | 1 | 2010 | 156 | 0.020 |
Why?
| Transducin | 1 | 2009 | 42 | 0.020 |
Why?
| GTP-Binding Protein alpha Subunits | 1 | 2009 | 14 | 0.020 |
Why?
| Retinal Cone Photoreceptor Cells | 1 | 2009 | 16 | 0.020 |
Why?
| CLOCK Proteins | 1 | 2008 | 6 | 0.020 |
Why?
| Periodicity | 1 | 2008 | 57 | 0.020 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2009 | 175 | 0.020 |
Why?
| Young Adult | 1 | 2024 | 12455 | 0.020 |
Why?
| Sensory Deprivation | 1 | 2008 | 7 | 0.020 |
Why?
| Feedback, Physiological | 1 | 2008 | 76 | 0.020 |
Why?
| Case-Control Studies | 1 | 2015 | 3378 | 0.020 |
Why?
| Blood Glucose | 1 | 2018 | 2100 | 0.020 |
Why?
| Zebrafish | 1 | 2012 | 460 | 0.020 |
Why?
| Mice, Mutant Strains | 1 | 2008 | 298 | 0.020 |
Why?
| Proteoglycans | 1 | 2008 | 109 | 0.020 |
Why?
| Calcium Channel Agonists | 1 | 2006 | 12 | 0.020 |
Why?
| Flavoproteins | 1 | 2006 | 8 | 0.020 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 110 | 0.020 |
Why?
| ARNTL Transcription Factors | 1 | 2006 | 16 | 0.020 |
Why?
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2005 | 1 | 0.020 |
Why?
| Photoperiod | 1 | 2006 | 46 | 0.020 |
Why?
| Quinpirole | 1 | 2005 | 10 | 0.020 |
Why?
| Cryptochromes | 1 | 2006 | 23 | 0.020 |
Why?
| Kainic Acid | 1 | 2005 | 34 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2007 | 307 | 0.020 |
Why?
| Excitatory Amino Acid Agonists | 1 | 2005 | 40 | 0.020 |
Why?
| Cell Nucleus | 1 | 2009 | 584 | 0.020 |
Why?
| Calcium Channel Blockers | 1 | 2006 | 161 | 0.020 |
Why?
| Adolescent | 1 | 2024 | 20412 | 0.020 |
Why?
| Rats, Inbred F344 | 1 | 2005 | 259 | 0.010 |
Why?
| Receptors, Dopamine D2 | 1 | 2005 | 90 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2010 | 2395 | 0.010 |
Why?
| Animals, Newborn | 1 | 2007 | 835 | 0.010 |
Why?
| Calcium Signaling | 1 | 2006 | 250 | 0.010 |
Why?
| Physical Conditioning, Animal | 1 | 2006 | 229 | 0.010 |
Why?
| Prospective Studies | 1 | 2015 | 7135 | 0.010 |
Why?
| Hydroxyindoleacetic Acid | 1 | 2001 | 26 | 0.010 |
Why?
| Dose-Response Relationship, Drug | 1 | 2005 | 2011 | 0.010 |
Why?
| Injections, Subcutaneous | 1 | 2001 | 147 | 0.010 |
Why?
| Prodrugs | 1 | 2001 | 48 | 0.010 |
Why?
| Gene Expression | 1 | 2006 | 1465 | 0.010 |
Why?
| Membrane Proteins | 1 | 2006 | 1125 | 0.010 |
Why?
| Drug Administration Schedule | 1 | 2001 | 767 | 0.010 |
Why?
| Aging | 1 | 2009 | 1778 | 0.010 |
Why?
| Reactive Oxygen Species | 1 | 2001 | 593 | 0.010 |
Why?
| Intestines | 1 | 2001 | 347 | 0.010 |
Why?
| Brain | 1 | 2010 | 2673 | 0.010 |
Why?
| Time Factors | 1 | 2005 | 6555 | 0.010 |
Why?
|
|
Pozdeyev's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|